Trials / Completed
CompletedNCT00418054
Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C
Phase II, Multi-Center, Randomized, Double-Blind Study of Nitazoxanide Tablets Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Chronic Hepatitis C
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Romark Laboratories L.C. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of nitazoxanide-peginterferon alfa-2b combination therapy compared to peginterferon monotherapy in patients that are treatment naive or pre-treated for 24 weeks with nitazoxanide monotherapy in the treatment of chronic hepatitis C.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitazoxanide plus peginterferon alfa-2b | |
| DRUG | Peginterferon alfa-2b |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-07-01
- First posted
- 2007-01-04
- Last updated
- 2007-01-04
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT00418054. Inclusion in this directory is not an endorsement.